Cardionomic Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Series A2
  • Latest Deal Amount
  • $15.8M
Latest Deal Amount
  • Investors
  • 4

Cardionomic General Information

Description

Provider of cardiac treatments intended to be used for treating acute decompensated heart failure. The company's treatments address the condition's root cause of reduced contractility using neuromodulation to increase contractility, thus improving cardiac output and increasing renal flow or end-organ perfusion, enabling healthcare practitioners to decrease negative hormonal signaling and improve in-hospital morbidity and mortality.

Contact Information

Website
www.cardionomicinc.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Healthcare Technology Systems
Therapeutic Devices
Primary Office
  • 601 Campus Drive
  • Suite 12
  • New Brighton, MN 55112
  • United States
+1 (651) 000-0000

Cardionomic Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardionomic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A2) 21-Feb-2020 $15.8M 000.00 000.00 Completed Startup
3. Later Stage VC (Series A1) 30-Apr-2018 000 000.00 000.00 Completed Startup
2. Early Stage VC (Series A) 02-Oct-2015 $20M $22.4M Completed Startup
1. Early Stage VC (Series A) 01-Apr-2014 $2.35M $2.35M Completed Startup
To view Cardionomic’s complete valuation and funding history, request access »

Cardionomic Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A2 (NV) 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00
Series A1 (NV) 5,439,215 $0.001000 $0.12 $1.47 $1.47 1x $1.47 0%
Series A1 18,786,541 $0.001000 $0.13 $1.63 $1.63 1x $1.63 46.63%
To view Cardionomic’s complete cap table history, request access »

Cardionomic Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of cardiac treatments intended to be used for treating acute decompensated heart failure. The company's treatme
Surgical Devices
New Brighton, MN
11 As of 2020
000.00
00.00 0000-00-00
00000000000 000.00

00000000

at nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserun
00000000000 0000000
Durham, NC
00 As of 0000
000.00
0000000000 0 000.00

00000000

t. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pari
00000000000 0000000
Berlin, Germany
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cardionomic Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuroTronik Venture Capital-Backed Durham, NC 00 000.00 0000000000 0 000.00
000000000 Corporation Berlin, Germany
To view Cardionomic’s complete competitors history, request access »

Cardionomic Executive Team (4)

Name Title Board Seat Contact Info
Steve Goedeke Founder , Chief Executive Officer, President & Board Member
Michelle Kennefick Senior Director of Clinical and Research
Todd Kerkow Senior Vice President, Product Development
To view Cardionomic’s complete executive team members history, request access »

Cardionomic Board Members (12)

Name Representing Role Since
Ali Behbahani MD New Enterprise Associates Board Member 000 0000
Anthony Borowicz Integer Board Member 000 0000
Jonathan Heavey MD Cleveland Clinic Innovations Board Member 000 0000
Michael DeMane Self Board Member 000 0000
Steve Goedeke Cardionomic Founder , Chief Executive Officer, President & Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Cardionomic Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cardionomic Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cleveland Clinic Ventures Corporate Venture Capital Minority 000 0000 000000 0
Ascension Ventures Corporate Venture Capital Minority 000 0000 000000 0
Integer Corporation Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
To view Cardionomic’s complete investors history, request access »

Ready to get started?

Request a free trial